Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-070339
Filing Date
2025-05-13
Accepted
2025-05-13 16:10:25
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20250331.htm   iXBRL 10-Q 1975855
2 EX-4.1 bdsx-ex4_1.htm EX-4.1 37481
3 EX-4.2 bdsx-ex4_2.htm EX-4.2 42176
4 EX-31.1 bdsx-ex31_1.htm EX-31.1 15992
5 EX-31.2 bdsx-ex31_2.htm EX-31.2 16010
6 EX-32.1 bdsx-ex32_1.htm EX-32.1 8938
7 EX-32.2 bdsx-ex32_2.htm EX-32.2 9163
  Complete submission text file 0000950170-25-070339.txt   10035951

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bdsx-20250331.xsd EX-101.SCH 1847801
80 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20250331_htm.xml XML 1593596
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 25940164
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)